
GC64428
Etavopivat
Also known as (2S)-1-[5-(2,3-dihydro-[1,4]dioxino[2,3-b]pyridin-7-ylsulfonyl)-1,3,4,6-tetrahydropyrrolo[3,4-c]pyrrol-2-yl]-3-hydroxy-2-phenylpropan-1-one
Etavopivat is a potent, selective, orally bioavailable red blood cell (RBC) pyruvate kinase (PKR) activator
ChemicalCAS2245053-57-8MW457.5FormulaC22H23N3O6S
- CAS number
- 2245053-57-8
- Molecular weight
- 457.5
- Formula
- C22H23N3O6S
- Solubility
- DMSO : 50 mg/mL (109·29 mM; Need ultrasonic)
- InChIKey
- KZFFYEPYCVDOGE-LJQANCHMSA-N
- Catalogue number
- GC64428
- Brand
- GLPBIO
Computed properties PubChem CID 135338378 · XLogP -0.8 · TPSA 118 Ų · H-bond donors 1
- XLogP
- -0.8
- TPSA
- 118 Ų
- H-bond donors
- 1
- H-bond acceptors
- 8
- Rotatable bonds
- 5
- Heavy atoms
- 32
SMILES C1COC2=C(O1)C=C(C=N2)S(=O)(=O)N3CC4=C(C3)CN(C4)C(=O)[C@H](CO)C5=CC=CC=C5
Computed descriptors from PubChem (CID 135338378), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il